The CancerConnect Lung Cancer Newsletter

TraceyS

Stay Current With Lung Cancer Treatment Advances & Connect with Others

CancerConnect publishes daily cancer news, original articles and "tips" on the management of Lung Cancer. These are available in our monthly Lung Cancer newsletter.

Stay Current - Connect With Other Lung Cancer Patients

Join The CancerConnect Community: Connect with others and receive regular updates

Sign up for the Lung Cancer Newsletter Here

Comments

Lung Cancer

FEATURED

COMMUNITY

Treatment & Management of Non Small Cell Lung Cancer

Understand the role of precision cancer medicine, surgery, chemotherapy and radiation in the management of NSCLC.

Cancer Connect

Precision Cancer Medicines & Immunotherapy for Lung Cancer

Keep up with the growing number of precision medicines targeting specific mutations in lung cancer.

MedMaven

Overview of Lung Cancer

Lung Cancer; Risk factors, diagnostic evaluation, staging and treatment planning.

Cancer Connect

Treatment of Stage I - IIIA Non-Small Cell Lung Cancer

Update on the management of early stage NSCLC: precision medicines & immunotherapy changing the treatment landscape.

Cancer Connect

Xgeva Prevents Bone Complications Delays Recurrence & Prolongs Survival

Treatment of multiple myeloma and cancers that spread to bone all benefit from XGEVA treatment.

Cancer Connect

Enhertu Treatment of Her2 positive Non-Small Cell Lung Cancer

The precision cancer medicine Enhertu effectively targets HER2 over expressing NSCLC - trials ongoing.

MedMaven

Sotorasib (AMG 510) Precision Cancer Medicine Targets KRAS NSCLC

KRAS a major driver of lung and other cancers for KRAS G12C mutated NSCLC - what patients need to know.

MedMaven

Tecentriq® Improves Survival in Early and Advanced Stage NSCLC

Tecentriq® Checkpoint Inhibitor immunotherapy improves survival in early and advanced stage non-small cell lung cancers.

Cancer Connect

In Depth Overview of Tyrosine Kinase Inhibitor Treatment of EGFR + Lung Cancer

TKI therapy for EGFR + NSCLC continue to evolve and improve survival. Tagrisso resistance mutation recently identified.

Cancer Connect

Checkpoint Inhibitor - Chemotherapy for Treatment of Small Cell Lung Cancer

Tecentriq, Imfinzi, Opdivo, and Keytruda approved for treatment of small cell lung cancer, ASCO 2020 Update.

MedMaven